Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A spike-binding protein as a versatile tool to detect and inhibit transmissible gastroenteritis virus.

Virology·2026
Same author

Searching for α-solenoid proteins involved in organellar gene expression.

BMC genomics·2026
Same author

Monomeric Structure of Influenza A Virus NEP/NS2 Obtained With an Artificial Protein Highlights Conformational Plasticity.

Journal of molecular biology·2025
Same author

Inhibition of influenza virus replication by artificial proteins (αReps) targeting its RNA-polymerase.

Antiviral research·2025
Same author

Heligeom: A web resource to generate, analyze, and visualize filament architectures based on pairwise association geometries of biological macromolecules.

Journal of molecular biology·2025
Same author

pH Sensitivity of YFPs is Reduced Upon AlphaRep Binding: Proof of Concept in Vitro and in Living Cells.

Chembiochem : a European journal of chemical biology·2024

Related Experiment Video

Updated: Jun 23, 2026

Residue-Specific Exchange of Proline by Proline Analogs in Fluorescent Proteins: How "Molecular Surgery" of the Backbone Affects Folding and Stability
10:31

Residue-Specific Exchange of Proline by Proline Analogs in Fluorescent Proteins: How "Molecular Surgery" of the Backbone Affects Folding and Stability

Published on: February 3, 2022

Disulfide bond substitution by directed evolution in an engineered binding protein.

Antoine Drevelle1, Agathe Urvoas, Mériam Ben Hamida-Rebaï

  • 1Institut de Biochimie et Biophysique Moléculaire et Cellulaire, UMR 8619 CNRS, Université Paris Sud 11, 91405 Orsay cedex, France.

Chembiochem : a European Journal of Chemical Biology
|May 6, 2009
PubMed
Summary

Researchers engineered stable, disulfide-free neocarzinostatin (NCS) variants using directed evolution. This breakthrough enhances NCS

More Related Videos

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies
12:05

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies

Published on: March 6, 2013

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
12:16

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli

Published on: July 30, 2014

Related Experiment Videos

Last Updated: Jun 23, 2026

Residue-Specific Exchange of Proline by Proline Analogs in Fluorescent Proteins: How "Molecular Surgery" of the Backbone Affects Folding and Stability
10:31

Residue-Specific Exchange of Proline by Proline Analogs in Fluorescent Proteins: How "Molecular Surgery" of the Backbone Affects Folding and Stability

Published on: February 3, 2022

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies
12:05

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies

Published on: March 6, 2013

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
12:16

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli

Published on: July 30, 2014

Area of Science:

  • Protein Engineering
  • Biochemistry
  • Drug Delivery

Background:

  • Neocarzinostatin (NCS) is an antitumour protein used in human therapeutics and as a drug-carrying scaffold.
  • Disulfide bonds in NCS limit its potential applications, particularly for intracellular use.

Purpose of the Study:

  • To engineer stable, disulfide-free neocarzinostatin (NCS) variants.
  • To create a versatile NCS-derived scaffold suitable for diverse applications, including intracellular delivery.

Main Methods:

  • Employed a directed evolution approach starting from an engineered NCS variant with a hapten binding site.
  • Generated a mutant library by random substitution of cysteine residues (Cys88, Cys93) and neighboring residues.
  • Utilized phage display and colony filtration for selection of functional variants, followed by biophysical characterization.

Main Results:

  • Identified several disulfide-free NCS variants that retained hapten binding function.
  • Characterized the biophysical properties of selected variants, confirming enhanced stability and folding ability.
  • Molecular simulations provided insights into how selected sequences maintain protein integrity without disulfide bonds.

Conclusions:

  • Successfully developed a generic directed evolution strategy to create disulfide-free NCS variants.
  • These engineered variants offer improved stability and functionality for broader therapeutic and intracellular applications.
  • The disulfide-free NCS scaffold holds significant promise for advanced drug delivery systems.